# Surgical Pleth Index as a Potentially Useful and Noninvasive Tool for Assessing Tracheal Intubation Conditions in Female Patients During Neuromuscular Blockade‐Free Anesthesia

**Authors:** Jiale Chen, Zhihao Pan, Jinwei Zheng

PMC · DOI: 10.1155/emmi/7863986 · Emergency Medicine International · 2026-03-09

## TL;DR

This study shows that the Surgical Pleth Index (SPI) can help assess tracheal intubation conditions in female patients without using muscle-relaxing drugs.

## Contribution

The study introduces SPI as a noninvasive tool for evaluating intubation conditions in female patients without neuromuscular blockers.

## Key findings

- SPI values at specific time points correlated with intubation quality in female patients.
- SPI showed moderate predictive value for good intubation conditions in female patients.
- Blood pressure and heart rate changes were significant before and after intubation.

## Abstract

Neuromuscular blocking agents (NMBAs) are commonly used during tracheal intubation to ensure smoother procedural conditions, but they are associated with the risk of prolonged paralysis and respiratory complications. This study explores the relationship between the surgical pleth index (SPI) measured immediately before intubation and tracheal intubation conditions in patients who did not receive neuromuscular blockers, along with the predictive value of the SPI in these conditions.

A total of 100 surgical patients (excluded 17 patients who did not meet the eligibility criteria) undergoing elective surgery under general anesthesia at The Affiliated Lihuili Hospital of Ningbo University between November 2021 and June 2022 were included, and key parameters, including systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), and SPI, were measured at different time points (T0 to T5).

At T2, significant reductions in SBP, DBP, HR, and SPI were observed compared to baseline (T0, after the completion of 6 mL/kg of lactate Ringer’s solution infusion) and preintubation values (T1, at the time of loss of consciousness) (p < 0.05). Postintubation, both SBP and DBP significantly increased at T5 (3 min after intubation) compared to T2 (immediately before intubation) (p < 0.05). The patients were classified into “excellent” and “good” groups based on their intubation conditions. SPI values at T3 (immediately after intubation), T4 (1 min after intubation), and T5 were significantly higher in the “good” group compared to the “excellent” group (p < 0.05). Post hoc sex‐stratified receiver operating characteristic (ROC) analysis showed an area under the curve (AUC) of 0.713 (p = 0.037) and 95% confidence interval (CI) (0.539–0.887), indicating moderate predictive value for the SPI in assessing tracheal intubation conditions.

The SPI proves to be a potentially useful and noninvasive tool for evaluating tracheal intubation conditions in female patients without the use of NMBAs.

## Full-text entities

- **Genes:** CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** myasthenia gravis (MESH:D009157), neuromuscular blockade (MESH:D020879), neuromuscular disorders (MESH:D009468), allergies (MESH:D004342), postoperative muscle pain (MESH:D063806), peripheral or central nervous system disorders (MESH:D010523), malignant hyperthermia (MESH:D008305), aspiration (MESH:D011015), nausea and vomiting (MESH:D020250), cardiovascular disease (MESH:D002318), analgesia (MESH:D000699), systemic disease (MESH:D034721), hypoxemia (MESH:D000860), bradycardia (MESH:D001919), acoustic neuroma (MESH:D009464), hypotension (MESH:D007022), paralysis (MESH:D010243), NMBAs (MESH:D055191), arrhythmia (MESH:D001145), Anxiety (MESH:D001007), postoperative myalgia (MESH:D010149), pulmonary compromise (MESH:D008171), loss of consciousness (MESH:D014474), liver or kidney dysfunction (MESH:D051437), respiratory complications (MESH:D012140), Pain (MESH:D010146), inflammation (MESH:D007249), esophageal reflux (MESH:D005764)
- **Chemicals:** CO2 (MESH:D002245), rocuronium bromide (MESH:D000077123), ephedrine (MESH:D004809), EtCO2 (-), remifentanil (MESH:D000077208), norepinephrine (MESH:D009638), propofol (MESH:D015742), sodium lactate (MESH:D019354), atropine (MESH:D001285), water (MESH:D014867), Cortisol (MESH:D006854), Oxygen (MESH:D010100), midazolam (MESH:D008874), clonidine (MESH:D003000)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968434/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968434/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968434/full.md

---
Source: https://tomesphere.com/paper/PMC12968434